- US-listed companies
- FATE THERAPEUTICS INC
- Balance sheet
FATE THERAPEUTICS INC (FATE) Balance sheet
Market cap
$135.27M
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 54 | 49 | 65 | 89 | 89 | 191 | 100 | 167 | 134 | 61 | 42 | 36 |
| Marketable securities, current | - | - | - | 4 | - | - | - | - | - | 375 | 273 | 243 |
| Total cash & short-term investments | 54 | 49 | 65 | 92 | 89 | 191 | 100 | 167 | 134 | 436 | 315 | 279 |
| Accounts receivable, net | - | - | - | - | - | 1 | - | 6 | 9 | 38 | 2 | 4 |
| Total current assets | 55 | 50 | 66 | 93 | 103 | 205 | 227 | 494 | 633 | 502 | 332 | 292 |
| Property, plant and equipment, net | 1 | 1 | 2 | 2 | 3 | 5 | 11 | 32 | 92 | 110 | 97 | 64 |
| Marketable securities, non-current | - | - | - | - | - | - | 39 | - | 101 | 5 | 1 | 28 |
| Total non-current assets | 1 | 1 | 2 | 2 | 3 | 8 | 75 | 128 | 288 | 203 | 175 | 149 |
| Total assets | 56 | 51 | 68 | 95 | 105 | 213 | 302 | 622 | 921 | 706 | 506 | 441 |
| Accounts payable | 1 | 1 | 1 | 1 | 2 | 4 | 6 | 6 | 9 | 8 | 5 | 9 |
| Long-term debt, current | 2 | 2 | 8 | 8 | - | 2 | - | - | - | - | - | - |
| Total current liabilities | 5 | 5 | 13 | 15 | 11 | 27 | 28 | 86 | 81 | 114 | 39 | 39 |
| Long-term debt, non-current | - | 18 | 11 | 3 | 15 | 12 | - | - | - | - | - | - |
| Common stock and paid-in capital | 137 | 141 | 0 | 249 | 296 | 446 | 628 | 941 | 1,449 | 1,537 | 1,580 | 1,716 |
| Retained earnings | - | -112 | -142 | -176 | -219 | -285 | -384 | -557 | -769 | -1,051 | -1,212 | -1,398 |
| Stockholders' equity | 51 | 28 | 38 | 73 | 77 | 160 | 245 | 384 | 679 | 484 | 368 | 319 |
| Total debt | 2 | 20 | 18 | 11 | 15 | 15 | - | - | - | - | - | - |
| Net debt | -52 | -29 | -47 | -81 | -74 | -176 | - | - | - | - | - | - |
| D/E ratio (%) | 3.4 | 69.2 | 47.9 | 14.6 | 19.2 | 9.3 | - | - | - | - | - | - |